Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen, Verogen Partner for NGS-Based Human ID Product Development, Distribution

NEW YORK – Qiagen and Verogen said on Tuesday that they have signed a partnership to provide laboratories with tools and support for next-generation sequencing-based human identification workflows.

Under the partnership, Qiagen obtains the rights to globally distribute current and future Verogen products. In addition, the companies will collaborate to commercialize Verogen's forensically validated NGS workflows with Qiagen's sample prep automation to provide full sample-to-ID workflows for human ID labs.

"This partnership with Qiagen will make it easier for the laboratories to provide more impactful answers," Verogen CEO Brett Williams said in a statement. "By combining Verogen's industry-leading NGS-based product portfolio with Qiagen's gold-standard extraction, assay, and automation solutions, we can accelerate adoption and utilization of NGS in forensic operations."

Qiagen CEO Thierry Bernard added in a statement that the partnership "will drive the adoption of NGS in human identification as it will enable our customers to gain even better insights from their casework samples. This will ultimately strengthen justice systems all over the world."

In May, Verogen announced that it had partnered with Eurofins to implement NGS into routine forensic DNA casework.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.